OpenBilldrug price receipt

NADAC week of 2026-10-14

GLYBURIDE 2.5 MG TABLET

For 30 tablets

Pharmacies pay

$1.90 filed

30 × $0.06331 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$3.30 filed

30 × $0.11011 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.7× estimated

Medicare paid 1.7× what pharmacies pay.

Part D averages every strength and form sold under “Glyburide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.19 estimated

$1.90 + $0.29 (15%) + $5.00 fee per fill = $7.19

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

GLYBURIDE 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as glyburide.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Chartwell RX, LLC.

FDA’s Established Pharmacologic Class for it is Sulfonylurea.

The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.90 for 30 tablets (30 × $0.06331 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 4 labelers

LabelerNDCsPharmacies pay per unit
Teva Pharmaceuticals USA, Inc.5$0.06331 per EA filed
Modavar Pharmaceuticals LLC3$0.06331 per EA filed
Chartwell RX, LLC1$0.06331 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1$0.06331 per EA filed
All 10 NDCs, with labeler and price
  • 00093-8343-01 · Teva Pharmaceuticals USA, Inc. · $0.06331 per EA · eff. 2026-09-23 filed
  • 00093-8343-05 · Teva Pharmaceuticals USA, Inc. · $0.06331 per EA · eff. 2026-09-23 filed
  • 00093-8343-10 · Teva Pharmaceuticals USA, Inc. · $0.06331 per EA · eff. 2026-09-23 filed
  • 00093-8343-98 · Teva Pharmaceuticals USA, Inc. · $0.06331 per EA · eff. 2026-09-23 filed
  • 00093-9433-01 · TEVA Pharmaceuticals USA Inc · $0.06331 per EA · eff. 2026-09-23 filed
  • 23155-0057-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.06331 per EA · eff. 2026-09-23 filed
  • 62135-0584-30 · Chartwell RX, LLC · $0.06331 per EA · eff. 2026-09-23 filed
  • 72241-0039-05 · Modavar Pharmaceuticals LLC · $0.06331 per EA · eff. 2026-09-23 filed
  • 72241-0039-10 · Modavar Pharmaceuticals LLC · $0.06331 per EA · eff. 2026-09-23 filed
  • 72241-0039-11 · Modavar Pharmaceuticals LLC · $0.06331 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name glyburide with GLYBURIDE 2.5 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
GLYBURIDE 1.25 MG TABLET
generic · tablet
$0.06059 per EA filed
eff. 2026-09-23
$0.11011 per EA filed
Part D 2024 average
GLYBURIDE 2.5 MG TABLET this page
generic · tablet
$0.06331 per EA filed
eff. 2026-09-23
$0.11011 per EA filed
Part D 2024 average
GLYBURIDE 5 MG TABLET
generic · tablet
$0.06427 per EA filed
eff. 2026-09-23
$0.11011 per EA filed
Part D 2024 average
GLYBURIDE MICRO 3 MG TABLET
generic · tablet
$0.12808 per EA filed
eff. 2026-04-22
$0.23771 per EA filed
Part D 2024 average
GLYBURIDE MICRO 6 MG TABLET
generic · tablet
$0.23939 per EA filed
eff. 2026-04-22
$0.23771 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 10 NDCs’ NADAC prices is $0.06331 per EA filed.

Of the 20 other products in FDA’s Sulfonylurea class priced per EA, 14 have a higher middle NADAC price and 6 a lower one. The one in the middle is GLIPIZIDE ER 10 MG TABLET, at $0.12172 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $3.30 for 30 tablets, at an average of $0.11011 per EA in 2024 (2024-01-01 to 2024-12-31) for “Glyburide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 196,466 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for GLYBURIDE 2.5 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Glyburide / Glyburide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.